PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-09-02

Date Title Company
02-Sep-2019 International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk IAS; R3i
02-Sep-2019 Dutch Company Receives €20 Million for Skin Cancer Diagnostic Test SkylineDx
02-Sep-2019 International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk IAS; R3i
02-Sep-2019 North America Defibrillators Market to Grow Steadily During 2018–2023 P&S Intelligence
02-Sep-2019 Hansa Biopharma: Issue and Re-purchase of Class C Shares for Incentive Programme Hansa Biopharma AB
02-Sep-2019 LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases LifeArc
02-Sep-2019 ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA®▼ (edoxaban) in Elderly NVAF Patients Daiichi Sankyo Company, Limited
02-Sep-2019 ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA®▼ (edoxaban) in Elderly NVAF Patients Daiichi Sankyo Company, Limited
02-Sep-2019 Publication in Cancer Management and Research Underlines the Potential of Apogenix' Asunercept for the Treatment of Other Malignancies Beyond Glioblastoma and MDS Apogenix AG
02-Sep-2019 ISA Pharmaceuticals Strengthens its Supervisory Board with the Addition of Dr. Markwin Velders ISA Pharmaceuticals
02-Sep-2019 Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki Valo Therapeutics
02-Sep-2019 Creative Enzymes Has Recently Launched Three Advanced Enzyme Products for Diagnostics and therapeutics Creative Enzymes